{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:05:13Z","timestamp":1761512713342},"reference-count":32,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T00:00:00Z","timestamp":1249344000000},"content-version":"vor","delay-in-days":5329,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[1995,1]]},"abstract":"<jats:p><jats:bold>Abstract. <\/jats:bold> <jats:bold>Objectives<\/jats:bold>. To study the cardiovascular effects of human growth hormone (GH) replacement therapy in adults.<\/jats:p><jats:p><jats:bold>Intervention<\/jats:bold>. Biosynthetic human GH given in a daily dose of 0.04 \u00b1 0.01 IU kg<jats:sup>\u22121<\/jats:sup> for 6\u201318 months in an open trial.<\/jats:p><jats:p><jats:bold>Patients<\/jats:bold>. Thirty\u2010four GH\u2010deficient hypopituitary patients on conventional replacement therapy, aged 19\u201367 years and with a body mass index of 18.0\u2013410.0 kg\/m<jats:sup>2<\/jats:sup>.<\/jats:p><jats:p><jats:bold>Measurements<\/jats:bold>. Resting blood pressure, exercise tolerance, renal function and routine blood counts were assessed every 6 months. Two\u2010dimensional echocardiography and Doppler ultrasound scanning were performed at 0, 6 and 12 months of GH therapy.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold>. Exercise time increased significantly on GH from 9.37 \u00b1 2.64min at the start to 10.39 \u00b1 2.86 min (<jats:italic>P<\/jats:italic> &lt; 0.001), 10.90 \u00b1 2.48 min (<jats:italic>P<\/jats:italic> &lt; 0.001) and 11.11 \u00b1 0.70 min (<jats:italic>P<\/jats:italic> &lt; 0.001) at 6, 12 and 18 months respectively. There was no change in the heart rate or in the blood pressure at rest nor at the peak of exercise. No significant changes were observed in measures of cardiac structure (left ventricular mass index, left ventricular posterior wall thickness and interventricular septal thickness), ejection fraction nor in cardiac output. Isovolumic relaxation time, a marker of diastolic function, decreased in 24 patients after 6 months on GH (from 98.6 \u00b1 15.9 to 89.6 \u00b1 15.2 ms; <jats:italic>P<\/jats:italic> &lt; 0.03) but it was not different from baseline in the 18 patients who were restudied at 12 months. There was no significant change in the left ventricular filling neither at 6 nor at 12 months. No significant changes were observed in plasma electrolytes, creatinine nor in blood count on GH treatment.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold>. Growth hormone replacement therapy in hypopituitary adults for 6\u201318 months produced sustained increase in exercise tolerance but was not associated with changes in cardiac structure or systolic function.<\/jats:p>","DOI":"10.1111\/j.1365-2796.1995.tb01137.x","type":"journal-article","created":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T09:16:05Z","timestamp":1249377365000},"page":"35-42","source":"Crossref","is-referenced-by-count":28,"title":["Cardiovascular effects of prolonged growth hormone replacement in adults"],"prefix":"10.1111","volume":"237","author":[{"given":"S. A.","family":"BESHYAH","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"SHAHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"FOALE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. G.","family":"JOHNSTON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,4]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01797616"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91812-O"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.67.1.92"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.77.6.1658"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.77.6.1671"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000182573"},{"key":"e_1_2_1_8_2","first-page":"P128","article-title":"Does glucocorticoid replacement therapy contribute to the increased vascular risk in growth hormone deficient hypopituitary adults","volume":"140","author":"Beshyah SA","year":"1993","journal-title":"J Endocrinol"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92328-3"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0810587"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1152\/jappl.1991.70.2.695","article-title":"Growth hormone treatment in growth hormone deficient adults. II. Effects on exercise performance","volume":"70","author":"Cuneo RC","year":"1991","journal-title":"J Appl Physiol"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb02901.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb03937.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1300451"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb02358.x"},{"key":"e_1_2_1_16_2","first-page":"449","article-title":"Long\u2010term growth hormone treatment in growth hormone deficient adults","volume":"125","author":"Jorgensen JOL","year":"1991","journal-title":"Acta Endocrinol (Copenh)"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.32.4.742"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.56.1.33"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.63.6.1398"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)65673-0"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.59.6.672"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92892-J"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92664-F"},{"key":"e_1_2_1_24_2","first-page":"1","article-title":"Mortality in acromegaly","volume":"39","author":"Wright AD","year":"1970","journal-title":"Quarterly J Med"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1980.tb03135.x"},{"key":"e_1_2_1_26_2","first-page":"327","article-title":"Epidemiology and long term survival in acromegaly","volume":"223","author":"Bengtsson B\u2010A","year":"1988","journal-title":"Acta Med Scand"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1991.70.2.688"},{"key":"e_1_2_1_28_2","first-page":"185","article-title":"Physical and psychological capabilities during substitution therapy with recombinant growth treatment in adults with growth hormone deficiency","volume":"123","author":"Degerblad M","year":"1990","journal-title":"Acta Endocrinol"},{"key":"e_1_2_1_29_2","first-page":"41","article-title":"Quadriceps strength before and during growth hormone treatment in hypopituitary adults: relationship to changes in lean body mass and IGF\u2010I","volume":"1","author":"Rutherford OM","year":"1994","journal-title":"Endocrinol Metab"},{"key":"e_1_2_1_30_2","first-page":"P166","article-title":"Effects of long term growth hormone replacement in hypopituitary adults on body composition, exercise tolerance and muscle strength","volume":"140","author":"Beshyah SA","year":"1994","journal-title":"J Endocrinol"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(84)80207-6"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(87)90795-2"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(85)90741-6"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.1995.tb01137.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2796.1995.tb01137.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T01:36:43Z","timestamp":1698284203000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.1995.tb01137.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["10.1111\/j.1365-2796.1995.tb01137.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.1995.tb01137.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1]]}}}